Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram van den Broek

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Science Advances|December 12, 2025
Histone methyltransferase DOT1L maintains cell state and restricts cytotoxic potential of CD8 T cellsMuddassir Malik, Willem-Jan de Leeuw, Muhammad Assad Aslam, et al.
Cell Reports|May 20, 2023
Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumorsJinhyuk Bhin, Mariana Paes Dias, Ewa Gogola, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2025
Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trialChantal F Stockem, Jeroen van Dorp, Nick van Dijk, et al.
Nature Communications|July 17, 2021
Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancerStefan Prekovic, Karianne Schuurman, Isabel Mayayo-Peralta, et al.
Cancer Cell|June 13, 2018
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic LethalityEwa Gogola, Alexandra A Duarte, Julian R de Ruiter, et al.
Nature|March 25, 2015
REV7 counteracts DNA double-strand break resection and affects PARP inhibitionGuotai Xu, J Ross Chapman, Inger Brandsma, et al.
Nature|November 19, 2025
Tumour-reactive heterotypic CD8 T cell clusters from clinical samplesSofía Ibáñez-Molero, Johanna Veldman, Juan Simon Nieto, et al.
The British Journal of Surgery|February 28, 2024
Early experience with robotic pancreatoduodenectomy versus open pancreatoduodenectomy: nationwide propensity-score-matched analysisNine de Graaf, Maurice J W Zwart, Jony van Hilst, et al.
Annals of Surgery|June 8, 2023
The Feasibility, Proficiency, and Mastery Learning Curves in 635 Robotic Pancreatoduodenectomies Following a Multicenter Training Program: "Standing on the Shoulders of Giants"Maurice J W Zwart, Bram van den Broek, Nine de Graaf, et al.
Science (New York, N.Y.)|May 28, 2021
3D genomics across the tree of life reveals condensin II as a determinant of architecture typeClaire Hoencamp, Olga Dudchenko, Ahmed M O Elbatsh, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Science Advances|December 12, 2025
Histone methyltransferase DOT1L maintains cell state and restricts cytotoxic potential of CD8 T cellsMuddassir Malik, Willem-Jan de Leeuw, Muhammad Assad Aslam, et al.
Cell Reports|May 20, 2023
Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumorsJinhyuk Bhin, Mariana Paes Dias, Ewa Gogola, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2025
Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trialChantal F Stockem, Jeroen van Dorp, Nick van Dijk, et al.
Nature Communications|July 17, 2021
Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancerStefan Prekovic, Karianne Schuurman, Isabel Mayayo-Peralta, et al.
Cancer Cell|June 13, 2018
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic LethalityEwa Gogola, Alexandra A Duarte, Julian R de Ruiter, et al.
Nature|March 25, 2015
REV7 counteracts DNA double-strand break resection and affects PARP inhibitionGuotai Xu, J Ross Chapman, Inger Brandsma, et al.
Nature|November 19, 2025
Tumour-reactive heterotypic CD8 T cell clusters from clinical samplesSofía Ibáñez-Molero, Johanna Veldman, Juan Simon Nieto, et al.
The British Journal of Surgery|February 28, 2024
Early experience with robotic pancreatoduodenectomy versus open pancreatoduodenectomy: nationwide propensity-score-matched analysisNine de Graaf, Maurice J W Zwart, Jony van Hilst, et al.
Annals of Surgery|June 8, 2023
The Feasibility, Proficiency, and Mastery Learning Curves in 635 Robotic Pancreatoduodenectomies Following a Multicenter Training Program: "Standing on the Shoulders of Giants"Maurice J W Zwart, Bram van den Broek, Nine de Graaf, et al.
Science (New York, N.Y.)|May 28, 2021
3D genomics across the tree of life reveals condensin II as a determinant of architecture typeClaire Hoencamp, Olga Dudchenko, Ahmed M O Elbatsh, et al.
Pageof 5